MS4A1 and congenital rubella syndrome: Moreover, surface labeling of CAR-T cells by CD20 or tEGFR has been proposed to eliminate CAR-T cells via CD20 or EGFR-targeted antibodies during severe CRS (NCT03618381; NCT03085173).